EP3607068
RNA-víxlhrifamiðluð hindrun á TMPRSS6
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
5.4.2018EP published:
2.11.2022EP application number:
18715705.2
EP translation filed:
16.1.2023Grant published:
15.2.2023EPO information:
European Patent Register
Max expiry date:
4.4.2038Expiry date:
4.4.2026Next due date:
30.4.2026
Title in English:
RNA INTERFERENCE MEDIATED INHIBITION OF TMPRSS6Language of the patent:
English
Timeline
Today
5.4.2018EP application
2.11.2022EP Publication
16.1.2023Translation submitted
15.2.2023Registration published
4.4.2026Expires
Owner
Name:
Silence Therapeutics GmbHAddress:
Robert-Rössle-Strasse 10, 13125 Berlin, DE
Inventor
Name:
DAMES, SibylleAddress:
13125 Berlin, DE
Name:
SCHAEPER, UteAddress:
13125 Berlin, DE
Name:
HAUPTMANN, JudithAddress:
13125 Berlin, DE
Name:
FRAUENDORF, ChristianAddress:
13127 Berlin, DE
Name:
BETHGE, LucasAddress:
14473 Potsdam, DE
Name:
WEINGÄRTNER, AdrienAddress:
13125 Berlin, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
17165007Date:
5.4.2017Country:
EP
Number:
17201405Date:
13.11.2017Country:
EP
Classification
Categories:
C12N 15/113, A61K 31/713
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 24.3.2023
Expires: 4.4.2024
Payer: Árnason Faktor ehf.
Number: 7
Paid: 28.2.2024
Expires: 4.4.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 24.3.2025
Expires: 4.4.2026
Payer: Árnason Faktor ehf.